Android app Apple app link

Cullinan Oncology, Inc. (CGEM) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$15.22
Day's range
$16.49

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/17/2026 UBS David Dai $27.00 $20.76   30.06%
04/28/2026 H.C. Wainwright Robert Burns $30.00 $12.79   134.65%
03/10/2026 Stifel Nicolaus Alex Thompson $28.00 $15.11   85.36%
12/09/2025 Wedbush Robert Driscoll $34.00 $12.18   179.15%
11/24/2025 BTIG Julian Harrison $38.00 $11.90   219.26%
10/23/2024 UBS David Dai $30.00 $15.61   92.18%
08/08/2024 Morgan Stanley Jeffrey Hung $38.00 $16.38   131.99%
05/16/2024 H.C. Wainwright Edward White $28.00 $26.72   4.79%
04/17/2024 BTIG Kaveri Pohlman $30.00 $17.32   73.21%
04/16/2024 H.C. Wainwright Edward White $29.00 $17.63   64.54%

Cullinan Therapeutics Inc FAQ's

Cullinan Therapeutics Inc has been rated by research analysts at UBS, BTIG, Wedbush, H.C. Wainwright, Stifel Nicolaus, Guggenheim in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.